RXRX · Recursion Pharmaceuticals, Inc.

$2.96 -0.05 (-1.66%) At close · Jul 24

Market Cap

$1.57B

529.91M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	CEO	$680,000	—	$3,808,302	$4,846,699	$256,777	$15,731	$9,607,508
Najat Khan	CEO	$600,000	—	$1,944,547	$2,501,058	$256,777	$46,683	$5,349,065
Ben Taylor	CFO	$538,680	—	$253,881	$323,110	$205,226	$7,586	$1,328,483

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Najat Khan	Chief R&D Officer and Chief Commercial Officer	$285,000	$500,000	$3,647,774	$4,592,021	$115,824	$54,185	$9,194,805
Christopher C. Gibson	CEO	$600,000	—	$3,364,500	$4,274,816	$241,865	$18,405	$8,499,587
Ben Taylor	CFO	$53,392	—	$2,255,389	$5,662,543	$200,327	—	$8,171,651
Tina Marriott	COO	$530,000	—	$2,259,736	$2,871,148	$213,648	$19,072	$5,893,604
Michael Secora	CFO	$475,000	—	$1,757,577	$2,233,116	—	$577,813	$5,043,506
David Mauro	Chief Medical Officer	$525,000	—	$502,159	$638,032	$211,626	$56,773	$1,933,590

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	CEO	$560,833	—	$3,478,140	$4,328,352	$224,483	$21,400	$8,613,209
Tina Marriott	COO	$485,733	—	$1,855,872	$2,309,529	$194,419	$22,092	$4,867,645
Michael Secora	CFO	$435,583	—	$1,730,759	$2,153,839	$174,369	$19,830	$4,514,381
David Mauro	Chief Medical Officer	$303,333	—	$1,672,553	$2,181,756	$121,634	$33,190	$4,312,466
Shafique Virani	Chief Corporate Development Officer	$520,417	—	$908,463	$1,130,537	$208,442	$36,182	$2,804,040

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	CEO	$497,500	—	$2,573,043	$3,047,682	$185,478	$12,200	$6,315,903
Tina Marriott	COO	$437,800	—	$984,017	$1,165,534	$163,289	$11,600	$2,762,240
Tina Marriott Larson	COO	$437,800	—	$984,017	$1,165,534	$163,289	$11,600	$2,750,640
Michael Secora	CFO	$348,250	—	$721,107	$845,127	$129,834	$46,104	$2,090,422
Shafique Virani	Chief Corporate Development Officer	$488,333	—	$497,181	$588,894	$181,906	$11,600	$1,767,914
Ramona Doyle	Chief Medical Officer	$167,933	—	$475,848	$563,625	—	$359,058	$1,207,406

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shafique Virani	Chief Corporate Development Officer	$500,000	—	—	—	$175,000	$13,174	$688,174
Christopher C. Gibson	CEO	$485,417	—	—	—	$175,000	$13,174	$673,591
Ramona Doyle	Chief Medical Officer	$440,282	—	—	—	$154,000	$13,174	$607,456
Tina Marriott Larson	COO	$428,771	—	—	—	$154,000	$13,174	$595,945
Tina Marriott	COO	$428,771	—	—	—	$154,000	$13,174	$595,945
Michael Secora	CFO	$307,708	$63,460	—	—	$126,000	$13,174	$510,342

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Secora	CFO	$170,833	$63,000	—	$3,431,798	$15,357	$37,500	$3,718,488
Christopher C. Gibson	CEO	$269,643	$13,000	—	$2,268,661	$20,444	$12,700	$2,584,448
Shafique Virani	Chief Corporate Development Officer	$413,541	$13,000	—	$991,749	$28,158	$20,523	$1,466,974
Ramona Doyle	Chief Medical Officer	$3,666	—	—	$1,134,331	—	—	$1,137,997
Tina Marriott Larson	COO	$408,192	$13,000	—	$226,866	$30,070	$12,700	$690,828

Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 60 filings 60 filers Visit website Investor relations